Jonathan L. Koff

5.5k total citations · 1 hit paper
49 papers, 2.8k citations indexed

About

Jonathan L. Koff is a scholar working on Pulmonary and Respiratory Medicine, Ecology and Epidemiology. According to data from OpenAlex, Jonathan L. Koff has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Ecology and 11 papers in Epidemiology. Recurrent topics in Jonathan L. Koff's work include Bacteriophages and microbial interactions (14 papers), Cystic Fibrosis Research Advances (12 papers) and Respiratory viral infections research (8 papers). Jonathan L. Koff is often cited by papers focused on Bacteriophages and microbial interactions (14 papers), Cystic Fibrosis Research Advances (12 papers) and Respiratory viral infections research (8 papers). Jonathan L. Koff collaborates with scholars based in United States, Germany and Japan. Jonathan L. Koff's co-authors include Benjamin K. Chan, Paul E. Turner, Kaitlyn E. Kortright, Jay A. Nadel, Iris F. Ueki, Matt X. G. Shao, Alastair G. Stewart, Belinda J. Thomas, Naftali Kaminski and Candice A. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Jonathan L. Koff

46 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria

2019 777 citations Kaitlyn E. Kortright, Benjamin K. Chan et al. Cell Host & Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan L. Koff United States	23	959	802	725	578	407	49	2.8k
Christopher D. Sibley Canada	30	1.5k 1.6×	1.1k 1.3×	176 0.2×	887 1.5×	470 1.2×	56	3.3k
Jerry W. Simecka United States	32	1.0k 1.1×	240 0.3×	309 0.4×	784 1.4×	738 1.8×	81	3.0k
María López Spain	28	1.4k 1.5×	169 0.2×	331 0.5×	404 0.7×	500 1.2×	76	3.1k
T. Koga Japan	41	1.5k 1.6×	566 0.7×	178 0.2×	683 1.2×	476 1.2×	138	4.9k
Yoon‐Keun Kim South Korea	27	3.0k 3.1×	338 0.4×	287 0.4×	380 0.7×	614 1.5×	49	4.2k
Taylor S. Cohen United States	29	1.2k 1.3×	856 1.1×	78 0.1×	865 1.5×	646 1.6×	57	3.1k
Tsute Chen United States	32	1.4k 1.5×	213 0.3×	210 0.3×	223 0.4×	390 1.0×	91	3.7k
Dieter Worlitzsch Germany	23	1.7k 1.8×	1.7k 2.1×	147 0.2×	204 0.4×	295 0.7×	38	3.1k
Brigitte König Germany	28	714 0.7×	222 0.3×	123 0.2×	374 0.6×	680 1.7×	100	2.5k
Brian P. Butler United States	17	1.2k 1.3×	414 0.5×	136 0.2×	308 0.5×	121 0.3×	29	2.5k

Countries citing papers authored by Jonathan L. Koff

Since Specialization

Citations

This map shows the geographic impact of Jonathan L. Koff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan L. Koff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan L. Koff more than expected).

Fields of papers citing papers by Jonathan L. Koff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan L. Koff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan L. Koff. The network helps show where Jonathan L. Koff may publish in the future.

Co-authorship network of co-authors of Jonathan L. Koff

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan L. Koff. A scholar is included among the top collaborators of Jonathan L. Koff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan L. Koff. Jonathan L. Koff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feinn, Richard, et al.. (2024). Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa. Respiratory Medicine and Research. 86. 101133–101133. 2 indexed citations

Cochrane, Christina, Benjamin K. Chan, Kaitlyn E. Kortright, et al.. (2024). Cystic Fibrosis Bacteriophage Study at Yale (CYPHY). A6808–A6808. 3 indexed citations

Dagher, Rania, Aigul Moldobaeva, Mia Madel Alfajaro, et al.. (2024). Human iPSC-Based Model of COPD to Investigate Disease Mechanisms, Predict SARS-COV-2 Outcome, and Test Preventive Immunotherapy. Stem Cells. 42(3). 230–250. 2 indexed citations

Zamora, Paula F., Catherine R. Armbruster, Daria Van Tyne, et al.. (2024). Lytic bacteriophages induce the secretion of antiviral and proinflammatory cytokines from human respiratory epithelial cells. PLoS Biology. 22(4). e3002566–e3002566. 11 indexed citations

Chan, Benjamin K., Kaitlyn E. Kortright, Christina Cochrane, et al.. (2023). 41 CYstic Fibrosis bacterioPHage study at Yale (CYPHY). Journal of Cystic Fibrosis. 22. S22–S22. 1 indexed citations

Harris, Z.M., Ying Sun, Lokesh Sharma, et al.. (2023). A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Pseudomonas aeruginosa Infections. Antibiotics. 12(4). 735–735. 2 indexed citations

Patton, Michael J., Carlos J. Orihuela, Kevin S. Harrod, et al.. (2023). COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Critical Care. 27(1). 34–34. 50 indexed citations

Sun, Ying, Buqu Hu, Gail Stanley, et al.. (2022). IFN- γ is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 68(1). 75–89. 10 indexed citations

Murray, Thomas S., Gail Stanley, & Jonathan L. Koff. (2022). Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis. Clinics in Chest Medicine. 43(4). 667–676. 8 indexed citations

10.

Conrad, Douglas, Joanne Billings, Charlotte C. Tenebäck, et al.. (2020). Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients. Journal of Cystic Fibrosis. 20(1). 91–96. 7 indexed citations

11.

Chan, Benjamin K., Isabel M. Ott, Z.M. Harris, et al.. (2020). Bacteriophage Therapy Decreases Pseudomonas Aeruginosa Lung Inflammation. A2977–A2977. 2 indexed citations

12.

Gabryszewski, Stanislaw J., Tania Wong Fok Lung, Medini K. Annavajhala, et al.. (2019). Metabolic Adaptation in Methicillin-Resistant Staphylococcus aureus Pneumonia. American Journal of Respiratory Cell and Molecular Biology. 61(2). 185–197. 39 indexed citations

13.

Kortright, Kaitlyn E., Benjamin K. Chan, Jonathan L. Koff, & Paul E. Turner. (2019). Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host & Microbe. 25(2). 219–232. 777 indexed citations breakdown →

14.

Kalinowski, April, Benjamin Galen, I. F. Ueki, et al.. (2018). Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunology. 11(3). 958–967. 65 indexed citations

15.

Ye, Yan, Ping Lin, Shirui Tan, et al.. (2017). DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia. The Journal of Immunology. 198(7). 2844–2853. 28 indexed citations

16.

Zhang, Pingxia, Jijun Cheng, Siying Zou, et al.. (2015). Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation. Nature Communications. 6(1). 6221–6221. 85 indexed citations

17.

Zhou, Yang, Jae‐Young Lee, Chang-Min Lee, et al.. (2012). Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-β-induced Pulmonary Fibrosis. Journal of Biological Chemistry. 287(50). 41991–42000. 123 indexed citations

18.

Blanc, P.D., Charles W. Hoopes, Jeffrey A. Golden, et al.. (2011). The Impact of Pretransplant Mechanical Ventilation on Short- and Long-Term Survival After Lung Transplantation. American Journal of Transplantation. 11(10). 2197–2204. 49 indexed citations

19.

Cox, Michael J., Martin Allgaier, Marshall Baek, et al.. (2010). Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients. PLoS ONE. 5(6). e11044–e11044. 339 indexed citations

20.

Koff, Jonathan L., Matt X. G. Shao, Suil Kim, Iris F. Ueki, & Jay A. Nadel. (2006). Pseudomonas Lipopolysaccharide Accelerates Wound Repair via Activation of a Novel Epithelial Cell Signaling Cascade. The Journal of Immunology. 177(12). 8693–8700. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact